Patients who have a chronic disease live with the hope that better treatments will be available to manage their symptoms or to cure their condition. The research and development of new medicines is a lengthy process fraught with pitfalls and high costs. We need to enrich the pipeline of early discovery targets that have significant potential for success. Sanofi, a Top 5 global pharmaceutical company, desires partners to find and develop novel research targets in the areas of cardiovascular disease, immunology, and neuroscience.
This is an electronic Request-for-Partners (eRFP) Challenge; the Solver will only need to submit a written proposal to be evaluated by the Seeker with the goal of establishing a collaborative partnership.
In order to address some of the world’s most significant unmet medical needs, it is important to understand the biology and etiology of these diseases. By selecting the appropriate targets and pathways to modulate, researchers can develop innovative therapies that could ultimately transform patients’ lives. Sanofi is committed to the prevention and treatment of serious global diseases and improving quality of life for all patients. Therefore, Sanofi is searching for partners to find and develop novel research targets in the areas of cardiovascular disease, immunology, and neuroscience.
This is an electronic Request-for-Partners (eRFP) Challenge. The Solver will write a preliminary proposal (up to 5 pages, including supporting non-confidential information and contact details) to be evaluated by Sanofi with a goal of establishing a collaborative partnership. Upon completion of the evaluation, Sanofi may contact selected Solvers directly to work out terms for a collaboration contract. The monetary value of the contract will vary depending on the amount of work to be delivered and the agreed upon time frame.
[NOTE: Only proposals from Solvers who have the ability to work as the collaboration partner will be considered. Furthermore, Sanofi may elect to make up to two awards of $5,000 each for the top 2 proposals across all categories. Solvers are eligible for multiple awards.]
Submissions to this Challenge must be received by 11:59 PM (US Eastern Time) on May 5, 2017.
Late submissions will not be considered.
ABOUT THE SEEKER
Sanofi, a global healthcare leader, discovers, develops, and distributes therapeutic solutions focused on patients’ needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur, and Consumer Healthcare. For more information, visit en.sanofi.com/.
InnoCentive is the global innovation marketplace where creative minds solve some of the world's most important problems for cash awards up to $1 million. Commercial, governmental and humanitarian organizations engage with InnoCentive to solve problems that can impact humankind in areas ranging from the environment to medical advancements.
What is an eRFP Challenge?
eRFPs allow Seekers to submit Requests for Proposals for a partner or supplier to provide materials or expertise to help solve a business challenge to the InnoCentive Solver community. This global community includes organizations and individuals, such as contract research organizations, scientists, university researchers, and technology companies.
After a Solver submits an eRFP response, the Seeker evaluates the responses to determine which Solver(s) to contact for further business discussions. With eRFPs, the Solver must not provide any confidential information in the eRFP response. If your eRFP response is selected, you negotiate the terms of the contract (including scope of work, tasks and duration) directly with the Seeker.
This Challenge type does not require Intellectual Property (IP) transfer. However, sometimes Challenges of this type do request that certain IP arrangements be made should a partnership be formed.